76 related articles for article (PubMed ID: 28242545)
1. Fructose-1,6-bisphosphate decreases IL-8 levels and increases the activity of pro-apoptotic proteins in HepG2 cells.
Krause GC; Lima KG; Haute GV; Schuster AD; Dias HB; Mesquita FC; Pedrazza L; Marczak ES; Basso BS; Velasque AC; Martha BA; Nunes FB; Donadio MV; de Oliveira JR
Biomed Pharmacother; 2017 May; 89():358-365. PubMed ID: 28242545
[TBL] [Abstract][Full Text] [Related]
2. Gallic acid reduces cell growth by induction of apoptosis and reduction of IL-8 in HepG2 cells.
Lima KG; Krause GC; Schuster AD; Catarina AV; Basso BS; De Mesquita FC; Pedrazza L; Marczak ES; Martha BA; Nunes FB; Chiela ECF; Jaeger N; Thomé MP; Haute GV; Dias HB; Donadio MVF; De Oliveira JR
Biomed Pharmacother; 2016 Dec; 84():1282-1290. PubMed ID: 27810785
[TBL] [Abstract][Full Text] [Related]
3. Total alkaloids of Rubus aleaefolius Poir inhibit hepatocellular carcinoma growth in vivo and in vitro via activation of mitochondrial-dependent apoptosis.
Zhao J; Chen X; Lin W; Wu G; Zhuang Q; Zhong X; Hong Z; Peng J
Int J Oncol; 2013 Mar; 42(3):971-8. PubMed ID: 23338043
[TBL] [Abstract][Full Text] [Related]
4. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
[TBL] [Abstract][Full Text] [Related]
5. Osthole induces G2/M cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells.
Chao X; Zhou X; Zheng G; Dong C; Zhang W; Song X; Jin T
Pharm Biol; 2014 May; 52(5):544-50. PubMed ID: 24236568
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-8 is related to poor chemotherapeutic response and tumourigenicity in hepatocellular carcinoma.
Park SY; Han J; Kim JB; Yang MG; Kim YJ; Lim HJ; An SY; Kim JH
Eur J Cancer; 2014 Jan; 50(2):341-50. PubMed ID: 24161763
[TBL] [Abstract][Full Text] [Related]
7. The α-iso-cubebenol compound isolated from Schisandra chinensis induces p53-independent pathway-mediated apoptosis in hepatocellular carcinoma cells.
Kim JE; Kim SG; Goo JS; Park DJ; Lee YJ; Hwang IS; Lee HR; Choi SI; Lee YJ; Oh CH; Choi YW; Hwang DY
Oncol Rep; 2012 Sep; 28(3):1103-9. PubMed ID: 22736046
[TBL] [Abstract][Full Text] [Related]
8. Rapamycin and fructose-1,6-bisphosphate reduce the HEPG2 cell proliferation via increase of free radicals and apoptosis.
da Silva EF; Krause GC; Lima KG; Haute GV; Pedrazza L; Mesquita FC; Basso BS; Velasquez AC; Nunes FB; de Oliveira JR
Oncol Rep; 2016 Nov; 36(5):2647-2652. PubMed ID: 27665945
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the JNK signaling pathway increases sensitivity of hepatocellular carcinoma cells to cisplatin by down-regulating expression of P-glycoprotein.
Liu XY; Liu SP; Jiang J; Zhang X; Zhang T
Eur Rev Med Pharmacol Sci; 2016; 20(6):1098-108. PubMed ID: 27049263
[TBL] [Abstract][Full Text] [Related]
10. Macrolide antibiotics differentially influence human HepG2 cytotoxicity and modulate intrinsic/extrinsic apoptotic pathways in rat hepatocellular carcinoma model.
Abdel-Hamid NI; El-Azab MF; Moustafa YM
Naunyn Schmiedebergs Arch Pharmacol; 2017 Apr; 390(4):379-395. PubMed ID: 28070612
[TBL] [Abstract][Full Text] [Related]
11. Notch1 downregulation combined with interleukin-24 inhibits invasion and migration of hepatocellular carcinoma cells.
Han B; Liu SH; Guo WD; Zhang B; Wang JP; Cao YK; Liu J
World J Gastroenterol; 2015 Sep; 21(33):9727-35. PubMed ID: 26361419
[TBL] [Abstract][Full Text] [Related]
12. Simvastatin induces growth inhibition and apoptosis in HepG2 and Huh7 hepatocellular carcinoma cells via upregulation of Notch1 expression.
Huang X; Ma J; Xu J; Su Q; Zhao J
Mol Med Rep; 2015 Mar; 11(3):2334-40. PubMed ID: 25412322
[TBL] [Abstract][Full Text] [Related]
13. Anti-tumor effect of germacrone on human hepatoma cell lines through inducing G2/M cell cycle arrest and promoting apoptosis.
Liu Y; Wang W; Fang B; Ma F; Zheng Q; Deng P; Zhao S; Chen M; Yang G; He G
Eur J Pharmacol; 2013 Jan; 698(1-3):95-102. PubMed ID: 23117090
[TBL] [Abstract][Full Text] [Related]
14. Acetylsalicylic acid-induced oxidative stress, cell cycle arrest, apoptosis and mitochondrial dysfunction in human hepatoma HepG2 cells.
Raza H; John A; Benedict S
Eur J Pharmacol; 2011 Oct; 668(1-2):15-24. PubMed ID: 21722632
[TBL] [Abstract][Full Text] [Related]
15. Deoxyelephantopin induces apoptosis in HepG2 cells via oxidative stress, NF-κB inhibition and mitochondrial dysfunction.
Mehmood T; Maryam A; Zhang H; Li Y; Khan M; Ma T
Biofactors; 2017 Jan; 43(1):63-72. PubMed ID: 27628030
[TBL] [Abstract][Full Text] [Related]
16. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
Wu WL; Wang WY; Yao WQ; Li GD
Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
[TBL] [Abstract][Full Text] [Related]
17. Induction of apoptosis by pectenotoxin-2 is mediated with the induction of DR4/DR5, Egr-1 and NAG-1, activation of caspases and modulation of the Bcl-2 family in p53-deficient Hep3B hepatocellular carcinoma cells.
Shin DY; Kim GY; Kim ND; Jung JH; Kim SK; Kang HS; Choi YH
Oncol Rep; 2008 Feb; 19(2):517-26. PubMed ID: 18202802
[TBL] [Abstract][Full Text] [Related]
18. Immunomodulatory effect of fructose-1,6-bisphosphate on T-lymphocytes.
Bordignon Nunes F; Meier Graziottin C; Alves Filho JC; Lunardelli A; Caberlon E; Peres A; Rodrigues De Oliveira J
Int Immunopharmacol; 2003 Feb; 3(2):267-72. PubMed ID: 12586607
[TBL] [Abstract][Full Text] [Related]
19. Pentoxifylline induces apoptosis of HepG2 cells by reducing reactive oxygen species production and activating the MAPK signaling.
Wang Y; Dong L; Li J; Luo M; Shang B
Life Sci; 2017 Aug; 183():60-68. PubMed ID: 28583366
[TBL] [Abstract][Full Text] [Related]
20. α-Hispanolol sensitizes hepatocellular carcinoma cells to TRAIL-induced apoptosis via death receptor up-regulation.
Mota A; Jiménez-Garcia L; Herránz S; de Las Heras B; Hortelano S
Toxicol Appl Pharmacol; 2015 Aug; 286(3):168-77. PubMed ID: 25930665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
